Transcription factor binding site clusters identify target genes with similar tissue-wide expression and buffer against mutations. by Rogan, Peter & Lu, Ruipeng
Western University
Scholarship@Western
Biochemistry Publications Biochemistry Department
1-1-2019
Transcription factor binding site clusters identify
target genes with similar tissue-wide expression and
buffer against mutations.
Peter Rogan
The University of Western Ontario, progan@uwo.ca
Ruipeng Lu
The University of Western Ontario, rlu45@uwo.ca
Follow this and additional works at: https://ir.lib.uwo.ca/biochempub
Part of the Biochemistry Commons, Bioinformatics Commons, Computational Biology
Commons, and the Genomics Commons
Citation of this paper:
Lu R and Rogan PK. Transcription factor binding site clusters identify target genes with similar tissue-wide expression and buffer







   Transcription factor binding site clusters identify target
genes with similar tissue-wide expression and buffer against
































































 14 Dec 2018,  :1933 (First published: 7
)https://doi.org/10.12688/f1000research.17363.1
 08 Apr 2019,  :1933 (Latest published: 7
)https://doi.org/10.12688/f1000research.17363.2
v2
Page 1 of 33





 Peter K. Rogan ( )Corresponding author: progan@uwo.ca











The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
 © 2019 Lu R and Rogan PK. This is an open access article distributed under the terms of the  ,Copyright: Creative Commons Attribution Licence
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 Lu R and Rogan PK. How to cite this article: Transcription factor binding site clusters identify target genes with similar tissue-wide
 F1000Research 2019,  :1933 (expression and buffer against mutations [version 2; peer review: 2 approved] 7
)https://doi.org/10.12688/f1000research.17363.2
 14 Dec 2018,  :1933 ( ) First published: 7 https://doi.org/10.12688/f1000research.17363.1
Page 2 of 33
F1000Research 2019, 7:1933 Last updated: 01 MAY 2019
site sequences and represents the average binding strength of the 
TF3. Neighboring, likely coregulatory TFBSs were identified by 
information density-based clustering (IDBC), which takes into 
account both the spatial organization (i.e. intersite distances) 
and information density (i.e. Ri values) of TFBSs5.
TF binding profiles, either derived from in vivo ChIP-seq 
peaks6–8 or computationally detected binding sites and CRMs9, 
have been shown to be predictive of absolute gene expression lev-
elsusing a variety of tissue-specific ML classifiers and regression 
models. Because signal strengths of ChIP-seq peaks are not 
strictly proportional to strengths of the contained strongest 
TFBSs and are instead controlled by TFBS counts3,10, represent-
ing TF binding strengths by ChIP-seq signals may not be appro-
priate; nevertheless, both achieved similar accuracy11. CRMs have 
been formed by combining two or three adjacent TFBSs9, which 
is inflexible, as it arbitrarily limits the number of binding sites 
contained in a module, and does not consider differences between 
information densities of different CRMs. Chromatin structure 
(e.g. histone modification (HM) and DNase I hypersensitive 
sites (DHSs)) were also found to be statistically redundant with 
TF binding in explaining tissue-specific mRNA transcript abun-
dance at a genome-wide level7,8,12,13, which was attributed to the 
heterogeneous distribution of HMs across chromatin domains8. 
Combining these two types of data explained the largest frac-
tion of variance in gene expression levels in multiple cell lines7,8, 
suggesting that either contributes unique information to gene 
expression that cannot be compensated for by the other.
Previous studies have shown that a small subset of target 
genes bound by TFs were differentially expressed (DE) in the 
GM19238 cell line, upon knockdown with small interfering RNAs 
(siRNAs)14. TFBS counts were defined as the number of ChIP-
seq peaks overlapping the promoter, with the caveat that the 
number and strengths of the TFBSs in each peak were not 
known15. Correlation between total TFBS counts and gene expres-
sion levels across 10 different cell lines was more predictive 
of which were DE than by setting a minimum threshold count 
of TFBSs15. This has also been addressed by perturbing gene 
expression with CAS9-directed clustered regularly interspaced 
short palindromic repeats (CRISPR) of 10 different TF genes in 
K562 cells16. The regulatory effects of each TF were dissected 
by single cell RNA sequencing with a regularized linear 
computational model16. This revealed DE targets and new func-
tions of individual TFs, some of which were likely regulated 
through direct interactions at TFBSs in their corresponding 
promoters. ML classifiers have also been applied to predict targets 
of a single TF using features extracted from n-grams derived from 
consensus binding sequences17, or from TFBSs and homotypic 
binding site clusters5.
We investigated whether the predicted TFBS strengths, distribu-
tion and CRM composition in promoters substantially determines 
gene expression profiles of direct TF targets. A general ML frame-
work was developed by combining information theory-based 
TF binding profiles with DHSs. The approach predicts which 
genes have similar tissue-wide expression profiles, and conversely, 
DE direct TF targets. Upon selecting DHSs to define accessible 
            Amendments from Version 1
The manuscript has been extensively edited to improve clarity 
of the presentation. Sentence lengths were reduced. Duplicate 
terms and text were eliminated. The titles of the subsections of 
Results were revised to indicate the primary conclusions. Two 
paragraphs were moved to the Supplementary Methods. The 
revised manuscript is shortened by 400 words and approximately 
2 pages.
We addressed the impact of covariance between expression 
levels of developmentally related tissues from the same organ, 
by sequentially removing 12 of 13 brain tissues from the GTEx 
dataset prior to recomputing the Bray-Curtis Similarity index. We 
found multiple covarying brain tissue expression values to not 
significantly influence the set of most similar genes seen with all 
53 tissues in this analysis.
For the Decision Tree classifiers predicting transcription factor 
target genes, Gini importance values were computed to assess 
the relative contribution of the six ML features to their predictive 
power. For the CRISPR-perturbed TFs in the K562 cell line, 
clustering Features 1-3, particularly the TFBS cluster information 
densities (Feature 3), were most important. The TFBS-level 
Feature 5 comprising the distribution of strong binding sites 
accounts for the largest contribution to classifier performance for 
the 11 siRNA-perturbed TFs in the GM19238 cell line.
Additional file 1 now contains text from v1 of the manuscript as 
requested by a reviewer. Additional file 5 now contains the Gini 
scores for the machine learning features and the accuracy value 
of each individual round of 10-fold cross validation.
We now cite:
•    Zabet & Adryan (2015)-indicating properties of TF 
molecules that contributed to genome-wide binding 
profiles.
•    Ma et al. (2018)-describing spatially colocalized cis-
clusters of TFs and how these groups of TF constitute 
tissue specific regulatory subnetworks.
•    Applications of Bray-Curtis Similarity in genomics (https://
precision.fda.gov/challenges/3/view/results), geosocial 
networks (Chen at al., 2014; Chen et al., 2014), and 




The distinctive organization and combination of TFBSs and 
regulatory modules in promoters dictates specific expression 
patterns within a set of genes1. Clustering of multiple adja-
cent binding sites for the same TF (homotypic clusters) and for 
different TFs (heterotypic clusters) defines cis-regulatory modules 
(CRMs) in human gene promoters. Experimental studies have 
shown that these clusters can reinforce (and in some instances, 
amplify) the impact of individual TFBSs on gene expression 
through increasing binding affinities, facilitated diffusion mecha-
nisms and funnel effects2. Because tissue-specific TF-TF interac-
tions in TFBS clusters are prevalent, these features can assist in 
identifying correct target genes by altering binding specificities of 
individual TFs3. Previously, we derived iPWMs from ChIP-seq 
data that can accurately detect TFBSs and quantify their strengths 
by determining the associated Ri values (Rate of Shannon infor-
mation transmission for an individual sequence4). R
sequence (the area 
under the sequence logo) is the average of Ri values of all binding 
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promoter intervals, ML features that captured the spatial distribu-
tion and information theory-based TFBS compositions of CRMs 
were extracted from IDBC clusters. The intent of this frame-
work was to provide insight into the transcriptional program 
of genes with similar profiles by dissecting shared properties 
of their cis-regulatory element organization, without imposing 
strict constraints on the strengths and distributions of TFBSs. 
We first identify genes with comparable tissue-wide expression 
profiles by application of Bray-Curtis similarity18. Using tran-
scriptome data generated by CRISPR-16 and siRNA-based14 TF 
knockdowns, we predicted DE target genes with promoters that 
contain ChIP-seq peaks for these same TFs.
Methods
To identify genes with similar tissue-wide expression patterns, 
we formally define tissue-wide gene expression profiles and pair-
wise similarity measures between profiles of different genes. 
A general ML framework relates features extracted from the 
organization of TFBSs in these genes to their tissue-wide expres-
sion patterns. Since protein-coding (PC) sequences represent 
the most widely studied and best understood component of the 
human genome19, positives and negatives for deriving ML clas-
sifiers of predicted DE direct TF target genes encoding proteins 
(TF targets, below) were obtained from CRISPR- and siRNA- 
generated knockdown data.
Similarity between GTEx tissue-wide expression profiles of 
genes
We used data from the Genotype-Tissue Expression (GTEx, 
version 6p) project which measured expression levels for each 
gene in 53 tissues, in different numbers of individuals (5 to 
564). For each tissue population, the median expression value 
is given in RPKM (Reads Per Kilobase of transcript per Million 
mapped reads) for each gene20. Data are available on Zenodo21. 
To capture the tissue-wide overall expression pattern of a 
gene instead of within a single tissue, the tissue-wide expres-
sion profile of a gene was defined as its median RPKM across 
GTEx tissues, which is described by a 53-element vector 
(Equation 1). Note that different isoforms whose expression 
patterns may significantly differ from each other cannot be 
distinguished by this approach.
            1 2 53[ , , , ] ( )A A A AEP MEV MEV MEV in RPKM=               (1)
where EPA is the tissue-wide expression profile of Gene A, 1AMEV  
is the median expression value of Gene A in Tissue 1, 2AMEV  
is the median expression value of Gene A in Tissue 2, etc.
To discover other genes whose tissue-wide expression profiles 
are similar to a given gene, we computed the Bray-Curtis Simi-
larity (Equation 2) between the tissue-wide expression profiles 
of all gene pairs. Relative to other similarity measures (Table 1, 
Additional file 122), this function exhibits desirable properties, 
including: 1) being bounded between 0 and 1, 2) achieving maxi-
mal similarity of 1, if and only if two vectors are identical, and 
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Prediction of genes with similar tissue-wide expression 
profiles
The framework for predicting whether the tissue-wide expres-
sion profile of a gene resembles a particular gene is indicated in 
Figure 1 (panels A and B). The genomic locations of all DHSs 
in 95 cell types from the ENCODE project[23; hg38 assem-
bly] were filtered for known promoters24; these sequences were 
then scanned for TFBSs using 94 iPWMs corresponding to 
the primary binding motifs for 82 TFs3. Data are available on 
Zenodo21. Heterotypic TFBS clusters were detected with the IDBC 
algorithm by specifying a minimum threshold of 0.1*R
sequence 
for the Ri values of individual TFBS elements in potential clus-
ters; this eliminated weak binding sites detected with iPWMs 
corresponding to false positive, non-functional TFBSs3.
The seven information density-related ML features (Additional 
file 122) derived from each TFBS cluster included: 1) The 
distance between this cluster and the transcription start site 
(TSS), 2) The length of this cluster, 3) The information con-
tent of this cluster (i.e. the sum of Ri values of all TFBSs in this 
cluster), 4) The number of binding sites of each TF within this 
cluster, 5) The number of strong binding sites (Ri > Rsequence) 
of each TF within this cluster, 6) The sum of Ri values of bind-




Similarity metric Property 1†,‡ Property 2† Property 3†
Bray-Curtis √; [0,1] √ √
Euclidean √; (0,1] √ ×
Cosine √; [0,1] × √
Pearson correlation25 ×; [-1,1] × ×
Spearman correlation26 ×; [-1,1] × ×
†The symbols √ and ×, respectively, indicate that the similarity metric satisfies 
and does not satisfy the property. ‡The interval in each cell indicates the range 
in which the result computed by the similarity metric lies.
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Ri values of strong binding sites (Ri > Rsequence) of each TF 
within this cluster.
Each of the Features 1–3 was defined in a gene as a vector, 
whose size equalled the number of clusters in the gene pro-
moter; each cluster was mapped to a single value in the vector. In 
Features 4–7, each cluster itself was mapped to a vector corre-
sponding to binding sites for 82 TFs (Additional file 122). If two 
genes contained different numbers of clusters, the maximum 
number of clusters among all instances was determined, and null 
clusters were added to the 5’ end of promoters with the smaller 
numbers of clusters; this enabled all genes to exhibit the same 
cluster counts. This allowed all genes to be used as training 
data for ML classifiers. Default parameter values for these 
classifiers were used to generate ROC curves with a built-in 
MATLAB function (Additional file 122).
Prediction of TF targets
Perturbed target gene expression after CRISPR-based mutation 
of TF genes. Dixit et al. performed CRISPR-based perturbation 
experiments using multiple guide RNAs for each of ten TFs in 
K562 cells, resulting in a matrix of coefficients indicating the effect 
of each guide RNA on each of 22,046 genes16. Data are available on 
Zenodo21. The coefficient of a guide RNA is defined as the log10 
fold change in gene expression level16. We previously derived 
iPWMs for the primary binding motifs of 7 of the ten TFs 
(EGR1, ELF1, ELK1, ETS1, GABPA, IRF1, YY1)3. The frame-
work for predicting TF targets (Figure 1A and 1C) was applied to 
these TFs. We defined a positive TF target gene in a cell line as :
1)    The fold change in the expression level of this gene for 
each of the guide RNAs of the TF was consistently 
greater than (or is less than) 1, which eliminated genes 
exhibiting both increased and decreased expression lev-
els for different guide RNAs, and increased the possibil-
ity that the gene was downregulated (or upregulated) by 
the TF (Additional file 122). and
2)    The average fold change in the expression level of this 
gene for all guide RNAs of the TF was greater than the 
threshold 𝜀 (or is less than 1/𝜀), and
Figure  1. The general  framework  for  predicting genes with  similar  tissue-wide  expression profiles  and TF  targets. Red and blue 
contents are respectively specific to prediction of genes with similar tissue-wide expression profiles and prediction of TF targets. (A) An 
overview of the ML framework. The steps enclosed in the dashed rectangle vary across prediction of genes with similar tissue-wide expression 
profiles and TF targets. The step with a dash-dotted border that intersects promoters with DHSs is a variant of the primary approach. 
In the IDBC algorithm (Additional file 122), the parameter I is the minimum threshold on the total information contents of TFBS clusters. 
In prediction of genes with similar tissue-wide expression profiles, the minimum value was 939, which was the sum of mean information 
contents (Rsequence values) of all 94 iPWMs; in prediction of direct targets, this value was the Rsequence value of the single iPWM used to 
detect TFBSs. The parameter d is the radius of initial clusters in base pairs, whose value, 25, was determined empirically. The seven ML 
features derived from TFBS clusters are described in the Methods section. The performance of seven different classifiers was evaluated 
with ROC curves and 10-fold cross validation (Additional file 122). (B) Obtaining the positives and negatives for identifying genes with 
similar tissue-wide expression profiles to a given gene (Additional file 222). (C) Obtaining the positives and negatives for predicting target 
genes of seven TFs using the CRISPR-generated perturbation data in K562 cells (Additional file 322). (D) Obtaining the positives and 
negatives for predicting target genes of 11 TFs using the siRNA-generated knockdown data in GM19238 cells (Additional file 422).
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3)    The promoter interval (10 kb) upstream of a TSS of this 
gene overlapped a ChIP-seq peak of the TF in the cell 
line.
If the coefficients for all guide RNAs of the TF for a gene were 
zero, the gene was defined as a negative (i.e. a non-target gene). 
As the threshold ε increases, the number of positives strictly 
decreases. As ε decreases, we have lower confidence that the posi-
tives were DE as a result of the TF perturbation. We balanced the 
number of positives obtained against our confidence that they 
were DE by evaluating different values of ε (i.e. 1.01, 1.05 and 
1.1; Additional file 122). For each TF, all ENCODE ChIP-seq 
peak datasets from the K562 cell line were merged to deter-
mine positives. Data are available on Zenodo21. To avoid imbal-
anced datasets that significantly compromised the classifier 
performance27, the Bray-Curtis function was applied to com-
pute the similarity values in the tissue-wide expression profile 
between all negatives and the positive gene with the largest aver-
age coefficient, and then negatives with the smallest values were 
selected, resulting in the same number of positive and negative 
genes (Figure 1C).
Because TFs may exhibit tissue-specific sequence preferences 
due to different sets of target genes3, the K562 cell line-derived 
iPWMs of EGR1, ELK1, ELF1, GABPA, IRF1, YY1 were used 
to detect binding sites in DHS-intersected intervals; for ETS1, 
we used the only available iPWM from GM128783. Six features 
(Features 1-5 and 7) were derived from each homotypic cluster 
(i.e. Feature 6 became identical to Feature 3, because only bind-
ing sites from a single TF were used) (Figure 1A). The results of 
10 rounds of 10-fold cross validation were averaged to evaluate 
the accuracy of the classifier.
Target gene expression changes after siRNA-based knock-
down of TFs. Significant changes in expression of target genes 
upon knockdown of 59 TFs in the GM19238 line were identified 
from the probability of differences in expression level (P-value) 
relative to the null hypothesis of no change14. Data are available 
on Zenodo21. DE genes with larger changes exhibited smaller 
P-values. The distribution of ChIP-seq peaks were considered to be 
evidence of TF binding to the promoters of these genes14. Among 
these 59 TFs, we have previously derived iPWMs exhibiting 
primary binding motifs for 11 (BATF, JUND, NFE2L1, PAX5, 
POU2F2, RELA, RXRA, SP1, TCF12, USF1, YY1)3. For this 
reason, transcription targets of these TFs were predicted in the 
GM19238 cell line (Figure 1A, D).
For ML training, we defined a positive (i.e. a target gene) for a 
TF, if the P-value of this gene was ≤ 0.01, and the promoter 
interval up to 10 kb upstream of a TSS overlapped one or more 
ChIP-seq peaks of the TF in GM12878. Other genes with 
P-values > 0.01 exhibited insufficient support for being TF 
targets and were labeled as negatives.
The iPWMs from GM19238 were used to detect binding sites 
for all TFs except for RELA, RXRA and NFE2L1. The iPWM 
from the GM19099 line was used for RELA, and for RXRA 
and NFE2L1, the only available iPWMs were derived from 
HepG2 and K562 cells, respectively. The DHSs in GM19238 
were first remapped to the hg38 assembly using liftOver, prior to 
being intersected with known promoters28. Data are available on 
Zenodo21. Although the knockdowns were performed in 
GM19238, GM12878 and GM19099 are also lymphoblastic cell 
lines, with GM19099 and GM19238 both being derived from 
the Yoruban population. For this analysis, the iPWMs derived 
in GM12878 and GM19099 were more appropriate sources 
of accessible TFBSs than those from HepG2 and K562, since 
GM12878 and GM19099 are more likely comparable to GM19238 
than HepG2 and K562. ML results were evaluated by averaging 
cross validation, as described above.
Mutation analyses on promoters of TF targets
To understand the significance of individual binding sites on 
the regulatory state of TF targets, we evaluated the effects of 
sequence changes in TFBSs that altered the Ri values of these 
sites, the definition of TF clusters, and whether consequen-
tial IDBC-related changes impacted the prediction of TF target 
genes. For example, mutations were sequentially introduced into 
the strongest binding sites in TFBS clusters of the EGR1 target 
gene, MCM7, to determine the threshold for cluster formation 
and whether disappearing clusters disabled MCM7 expression. 
For one target gene of each TF from the CRISPR-generated per-
turbation data, effects of naturally occurring TFBS variants 
present in dbSNP29 were also evaluated to explore aspects of 
TFBS organization that enabled both clusters and promoter activ-
ity to be resilient to binding site mutations. This was done by 
analyzing whether the occurrence of individual or multiple sin-
gle nucleotide polymorphisms (SNPs) lead to the loss of binding 
sites and the corresponding clusters, and resulted in changes in 
the predictions for these targets.
Results
The Bray-Curtis Function can accurately quantify the 
similarity between tissue-wide gene expression profiles
We computed the similarity values (Equation 2) between the 
tissue-wide expression profiles of the glucocorticoid recep-
tor (GR or NR3C1) gene and all other 18,812 PC genes to find 
genes with related profiles. NR3C1 is an extensively character-
ized TF with many known direct target genes30. As a constitutively 
expressed TF activated by glucocorticoid ligands, the protein 
mediates up-regulation of anti-inflammatory genes by binding as 
homodimers to glucocorticoid response elements. Transcription 
of proinflammatory genes is down-regulated by complexing 
with other activating TFs (e.g. NFKB and AP1), thereby eliminat-
ing their ability to bind and activate targets30. NR3C1 can bind 
its own promoter forming an auto-regulatory loop, which also 
contains functional binding sites of 11 other TFs (e.g. SP1, YY1, 
IRF1, NFKB) whose iPWMs have been developed and/or mutual 
interactions have been described previously3,30. The tissue-wide 
expression profile of NR3C1 comprises all different splicing and 
translational isoforms (GRα-A, GRα-B, GRα-C, GRα-D, GRβ, 
GRγ, GRδ). However, the profile averages out tissue-specific 
preferences of some isoforms, for example, GRα-C isoforms 
are significantly higher in the pancreas and colon, whereas lev-
els of GRα-D are highest in spleen and lungs30. We found that 
SLC25A32 and TANK have the greatest similarity in expression 
to NR3C1 (0.880 and 0.877 respectively), based on their overall 
similar expression patterns across the 53 tissues (Figure 2).
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The Decision Tree classifier performed best in prediction of 
genes with similar tissue-wide expression profiles
Several ML classifiers (Naïve Bayes, Decision Tree (DT), Random 
Forest and Support Vector Machines (SVM) with four different 
kernels) were evaluated to determine how well TFBS-related 
features could predict genes with tissue-wide expression pro-
files similar to NR3C1. Their performance were compared using 
ROC curves, for complete promoters or for accessible promoter 
sequences that were first intersected with DHSs (Figure 3). DT 
exhibited the largest AUC (area under the curve) under both 
Figure 2. GTEx  tissue-wide expression profiles of NR3C1, SLC25A32  and TANK. Visualization of the expression values (in RPKM) of 
these genes across 53 tissues from GTEx. For each gene, the colored rectangle belonging to each tissue indicates the valid RPKM of all 
samples in the tissue, the black horizontal bar in the rectangle indicates the median RPKM, the hollow circles indicate the RPKM of the 
samples considered as outliers, and the grey vertical bar indicates the sampling error. A comparison of the panels shows that the overall 
expression patterns of the three genes across the 53 tissues resemble each other (e.g. all three genes exhibit the highest expression levels 
in lymphocytes and the lowest levels in brain tissues).
Page 7 of 33
F1000Research 2019, 7:1933 Last updated: 01 MAY 2019
scenarios, and was one of two most stable classifiers (i.e. 
ΔAUC < 0.01), with the other being the SVM with RBF kernel. 
Consistent with previous findings10,31,32, inclusion of DHS infor-
mation significantly improved AUC values of the other classifiers 
with the exception of Naïve Bayes. In many instances, all 
TFBSs in a contiguous DHS interval formed a single binding 
site cluster.
The Decision Tree classifier was predictive of TF target 
genes
Based on its performance in distinguishing genes with NR3C1-
like tissue-wide expression profiles, the DT classifier was used 
to predict TF targets respectively based on the CRISPR-16 and 
siRNA-generated14 perturbation data. Performance was assessed 
with 10 rounds of 10-fold cross validation (Tables 2 & Table 3). 
Gini importance values were also used to assess the relative con-
tribution of the six ML features to the predictive power of the 
classifier (Additional file 522). For the CRISPR-perturbed TFs in 
the K562 cell line, clustering Features 1-3, particularly the TFBS 
cluster information densities (Feature 3), were most important. 
The TFBS-level Feature 5 comprising the distribution of strong 
binding sites accounts for the largest contribution to classifier 
performance for the 11 siRNA-perturbed TFs in the GM19238 
cell line. To assess the value of all ML features in capturing the 
distribution and composition of CRMs in promoters, all but 
one (TFBS counts) were sequentially removed, and the impact 
on accuracy of the classifier was determined. In each instance, 
classifier performance decreased, except for CRISPR-perturbed 
GABPA, IRF1 and YY1 upon inclusion of DHS information 
(Additional file 522).
The DT classifier predicted TF targets with greater sensitivity 
and specificity, after eliminating TFBSs in inaccessible promoter 
intervals in the CRISPR-generated knockdown data (Table 2). 
Specifically, predictions for EGR1, ELK1, ELF1, ETS1, GABPA, 
and IRF1 were more accurate than for YY1, which itself represses 
or activates a wide range of promoters by binding to sites over-
lapping the TSS (Table 2). Accordingly, perturbation results 
showed that YY1 has ~4-22 fold more PC targets in the K562 
cell line than the other TFs (ε = 1.05). Binding of YY1 more sig-
nificantly impacts the expression levels of target genes. The ratio 
of the PC targets at ε = 1.1 vs ε = 1.01 was 0.334, which signifi-
cantly exceeded those of other TFs in this study (0.017-0.082; 
Additional file 322). This is consistent with the extensive interac-
tions of this factor with many other TF cofactors in K562 cells, 
and its central role in specifying erythroid-specific lineage 
development3.
We found that promoters of most TF targets contain accessible, 
likely functional binding sites that are significantly correlated 
with changes in gene expression levels. Despite a high accu-
racy of target recognition, sensitivity did not exceed specificity, 
except for IRF1 (Table 2), due to a relatively large number of 
false negative genes. Promoters of non-targets are either devoid of 
Figure 3. Comparison between the performance of different classifiers in prediction of genes with similar tissue-wide expression 
profiles to NR3C1. (A) ROC curves and AUC of seven classifiers without intersecting promoters with DHSs. (B) ROC curves and AUC of 
seven classifiers after intersecting promoters with DHSs. The Decision Tree classifier exhibited the largest AUC under both scenarios, and 
inclusion of DHS information significantly improved other classifiers’ AUC except for Naïve Bayes.
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accessible binding sites, or these sites are non-functional. In 
these instances, the classifier was unable to distinguish between 
likely functional binding sites in targets and non-functional 
sites in non-targets. In vivo co-regulation mediated by interact-
ing cofactors, which was excluded by the classifier, assisted in 
distinguishing these non-functional sites that do not significantly 
affect gene expression14.
As the minimum differential expression threshold ε increased, 
the accuracy of the classifier for all the TFs monotonically 
increased, as expected (Figure 4). In general, more signifi-
cantly DE genes have been associated with a higher number of 
TFBSs in their promoters14. Thus, at greater ε, there are larger 
differences in the values of ML features derived from TFBS 
clusters between direct targets and non-targets.
Some TF target genes also display similar tissue-wide 
expression profiles to the TFs, themselves
To determine how many TF targets have similar tissue-wide 
expression profiles, we intersected the set of targets with the set 
of 500 PC genes with the most similar tissue-wide expression 
profiles for each TF (Table 4, Additional file 622). For exam-
ple, the B lymphocyte expression profiles of TFs PAX5 and 
POU2F2 are similar to their respective targets, IL21R and CD86. 
The intersected targets for YY1 include 21 and 7 nuclear 





Sensitivity Specificity Accuracy Sensitivity Specificity Accuracy
BATF 0.96 0.97 0.96 0.85 1 0.93
JUND 0.86 0.90 0.88 0.80 1 0.90
NFE2L1 0.92 0.95 0.94 0.71 0.93 0.82
PAX5 0.96 0.97 0.96 0.88 0.98 0.93
POU2F2 0.97 0.97 0.97 0.89 0.99 0.94
RELA 0.95 0.96 0.96 0.83 0.97 0.90
RXRA 0.93 0.91 0.92 0.84 0.95 0.89
SP1 0.98 0.98 0.98 0.89 0.99 0.94
TCF12 0.98 0.98 0.98 0.86 0.99 0.93
USF1 0.97 0.98 0.97 0.83 0.98 0.90
YY1 1 1 1 0.55 0.99 0.77
†The average performance of 10 rounds of 10-fold cross validation is indicated. The 
accuracy of each individual round is shown in Additional file 522. The siRNA-generated 





Sensitivity Specificity Accuracy Sensitivity Specificity Accuracy
EGR1 0.58 0.62 0.60 0.78 0.81 0.80
ELF1 0.59 0.65 0.62 0.83 0.87 0.85
ELK1 0.59 0.59 0.59 0.80 0.81 0.81
ETS1 0.59 0.6 0.59 0.81 0.81 0.81
GABPA 0.55 0.57 0.56 0.72 0.75 0.74
IRF1 0.54 0.55 0.54 0.76 0.64 0.70
YY1 0.50 0.51 0.51 0.45 0.69 0.57
†The average performance of 10 rounds of 10-fold cross validation when setting ε to 1.05 is 
indicated. The accuracy of each individual round is indicated in Additional file 522. The CRISPR-
generated knockdown data were obtained from Dixit et al.16.
Page 9 of 33
F1000Research 2019, 7:1933 Last updated: 01 MAY 2019
Figure 4. Accuracy of  the Decision Tree classifier when using 
three different values for. Each accuracy value was averaged from 
10 rounds of 10-fold cross validation. The minimum threshold ε of the 
average fold change in gene expression levels  (for all guide RNAs) 
of the TF was determined for fold changes: 1.01, 1.05 and 1.1. The 
accuracy value of each individual round is indicated in Additional 
file 522. As ε increased, accuracy for all seven TFs monotonically 
increased.
subunits of mitochondrial ribosomes), respectively, in the K562 
and GM19238 cell lines33. YY1 is known to upregulates a large 
number of mitochondrial genes by complexing with PGC-1α in 
C2C12 cells34, and genes involved in the mitochondrial respira-
tory chain in K562 cells16. Our results are consistent with the 
idea that YY1 may broadly regulate mitochondrial function 
within all 53 tissues, in addition to the erythrocyte, lymphocyte 
and skeletal muscle cell lines.
Between 0.4%–25% of genes with similar tissue-wide expres-
sion profiles to the TFs are actually their targets (Table 4). The 
majority are non-targets whose promoters contain non-functional 
binding sites that lack co-regulation by corresponding cofac-
tors. For YY1 and EGR1, we contrasted the flanking cofactor 
binding site distributions and strengths in the promoters of the 
most similarly expressed target genes (YY1: MRPL9, BAZ1B; 
EGR1: CANX, NPM1) with non-target genes (YY1: ADNP, 
RNF25; EGR1: GUCY2F, AWAT1). In these target gene promot-
ers, strong and intermediate TFBSs recognized by SP1, KLF1, 
CEBPB formed heterotypic clusters with adjacent YY1 sites. 
Additionally, TFBSs of SP1, KLF1, and NFY tended to be present 
adjacent to EGR1 binding sites (Additional file 722). These pat-
terns contrasted with enrichment of CTCF and ETV6 binding 
sites in gene promoters of YY1 and EGR1 non-targets (Additional 
file 722). Previous studies have reported that KLF1 is essential for 
terminal erythroid differentiation and maturation35. Direct physi-
cal interactions between YY1 and the constitutive activator SP1 
synergistically induce transcription36, through activating CEBPB 









ELF1 78 5 None
ELK1 112 4 GNL1(8th)
ETS1 267 15 None
GABPA 513 25 TAF1(1st)
IRF1 457 10 None
YY1
1752 127 MRPL9(2
nd), BAZ1B(6th), ENY2(7th), NUB1(8th), 
USP1(9th), HNRNPR(10th)
GM19238
1040 61 MED4(1st), SURF6(3rd), BAZ1B(6th)
BATF 186 21 None
JUND 44 2 None
NFE2L1 58 4 None
RELA 247 13 HMG20B(9th)
RXRA 181 3 None
SP1 1595 81 None
TCF12 655 20 None
USF1 301 21 None
PAX5 918 86 IL21R(8th)
POU2F2 532 26 CD86(3rd)
§The rank of each target in the list of similar genes in the descending order of Bray-Curtis similarity values is shown 
in the brackets immediately following the target.
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of K562 cells by binding the promoter of the G-CSFR gene 
encoding a hematopoietin receptor37. EGR1 and SP1 synergis-
tically cooperate at adjacent non-overlapping sites on EGR1 
promoter but compete for binding at overlapping sites38, whereas 
occupied CTCF binding sites often function as an insulator 
blocking the effects of cis-acting elements and preventing gene 
activation by mediating long-range DNA loops to alter topo-
logical chromatin structure39,40. ETV6, a member of the ETS 
family, is a transcriptional repressor required for bone marrow 
hematopoiesis and associated with leukemia development41.
Transcription factor binding site clusters buffer against 
expression changes from mutations in single sites
These results and previous studies indicate that the promoters 
of direct target genes contain multiple binding site clusters. We 
used our ML models of TFBS organization to investigate the 
effects of mutations in individual binding sites on the predicted 
expression of TF targets. We hypothesized that alternative TF 
clusters in the same promoter might stabilize and compensate 
for the loss of a mutated TF cluster, enabling mutated promoters 
to retain some capacity to regulate gene transcription upon TF 
binding. First, we introduced artificial variants into binding 
sites in silico in the promoter of the target gene MCM7 of EGR1 
and examined the effect on the output of the ML classifier 
(Figure 5). In the K562 line, MCM7 is upregulated by EGR1. 
Knockdown of MCM7 has an anti-proliferative and pro- 
apoptotic effect on K562 cells42 and the loss of EGR1 increases 
leukemia initiating cells43, which suggests that EGR1 may act as 
a tumor suppressor in K562 cells through the MCM7 pathway.
The strongest binding site (at position chr7:100103347[hg38], 
- strand, Ri = 12.0 bits) in the promoter was eliminated by a 
G->A mutation, resulting in the loss of Cluster 1 (Figure 5), 
which consists of two sites (the other site at chr7:100103339, 
-, 4.3 bits). The other two clusters comprising weaker 
binding sites of intermediate strength (chr7:100102252, +, 7.0 
bits; chr7:100102244, +, 1.3 bits; chr7:100101980, +, 8.9 bits; 
chr7:100101977, +, 2.2 bits; chr7:100101984, +, 1.9 bits) were 
still predicted to compensate for this mutation, so that the promoter 
maintains the capacity to induce MCM7 expression (Figure 5). 
Adjacent sites within the same TFBS cluster, which may 
individually not have sufficient affinity to strongly bind TFs 
and activate transcription, are capable of stabilizing binding to 
adjacent sites2. Weaker sites can direct TF molecules to strong 
sites and extend the duration of physical association, termed the 
funnel effect2. Binding stabilization between adjacent sites and 
the funnel effect enable CRMs comprised of information-dense 
clusters to be robust to mutations in individual binding sites2,44. In 
this example, Clusters 2 and 3 were also respectively removed by 
G->T and C->G mutations abolishing the strongest site in either 
cluster, altering the prediction of the classifier, that is, EGR1 
is expected to fail to induce MCM7 transcription (Figure 5). 
The remaining four sparse weak sites do not form a cluster and 
cannot completely supplant the disrupted strong sites.
We then examined the predicted impacts of natural SNPs on 
binding site strengths, clusters and predicted the regulatory 
state of the promoter for a direct target of each of the seven 
TFs from the CRISPR-generated perturbation data (Table 5). 
We found that a single SNP (e.g. rs996639427 of EGR1) could 
affect the strengths of multiple binding sites within a cluster 
(Table 5). Apart from SNPs that are predicted to abolish binding 
(Figure 5), leaky variants that are expected to merely weaken 
TF binding are also common (Table 5). Neither mutations 
that abolish TFBSs nor leaky SNPs in flanking weak bind-
ing sites would be expected to inactivate TFBS clusters 
Figure 5. Mutation analyses on the target MCM7 of EGR1. This figure depicts the effect of a mutation in each EGR1 binding site cluster 
of the MCM7 promoter on the expression level of MCM7, which is a target of the TF EGR1. The strongest binding site in each cluster were 
abolished by a single nucleotide variant. Upon loss of all three clusters, only weak binding sites remained and EGR1 was predicted to no 
longer be able to effectively regulate MCM7 expression. Multiple clusters in the promoters of TF targets confer robustness against mutations 
within individual binding sites that define these clusters.
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§All coordinates are based on the hg38 genome assembly. A bold italic letter in a binding site sequence indicates the base where a SNP occurs. For each 
normal and variant binding site sequence, the genome coordinate of its most 5’-end base and its Ri value are indicated. The negative Ri value of a variant 
binding site sequence implies this site is abolished. The SNPs strengthening binding sites and corresponding variant binding site sequences are underlined.
‡The impact on whether the occurrence of a single SNP resulted in the disappearance of the cluster containing it is shown; ‘Abolished’ indicates that the 
cluster is eliminated by the existence of the variant allele.
†After a single SNP occurred or multiple SNPs simultaneously occurred, the classifier produced a new prediction on whether the TF is still capable of 
significantly affecting gene expression via the variant promoter.
(e.g. rs1030185383 and rs5874306 of IRF1), whereas SNPs with 
large reductions in Ri values of strong sites are more likely to 
abolish clusters (e.g. rs865922947, rs946037930, rs917218063 
and rs928017336 of YY1) (Table 5). Multiple TF clusters enable 
promoters to be resilient to the effects of these mutations; only 
the complete inactivation of all clusters by concurrent effects 
of multiple SNPs within TFBSs would be capable of making a 
promoter to be unresponsive to TF binding (e.g. rs997328042, 
rs1020720126 and rs185306857 of GABPA) (Table 5). Conversely, 
a small number of SNPs capable of strengthening TF binding and 
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reinforcing the regulatory effect of the TF were also observed 
(e.g. rs887888062 of EGR1 and rs751263172 of ELF1) (Table 5). 
In addition to deleterious mutations, potentially benign variants 
may also be found in promoters, consistent with the expectations 
of neutral theory45.
Discussion
In this study, the Bray-Curtis similarity function was initially 
shown (for the NR3C1 gene) to measure the relatedness of 
overall expression patterns between genes across a diverse set 
of tissues (Figure 2). A ML framework distinguished similar 
from dissimilar genes based on the distribution, strengths and 
compositions of TFBS clusters in accessible promoters, which 
can substantially account for the corresponding gene expres-
sion patterns (Figure 1 & Figure 3). Using gene expression 
knockdown data, the combinatorial use of TF binding profiles 
and chromatin accessibility was also demonstrated to be predic-
tive of TF targets (Figure 4, Table 2 & Table 3). A binding site 
comparison confirmed that coregulatory cofactors can be used 
to distinguish between functional sites in targets and non- 
functional ones in non-targets. Furthermore, in silico mutation 
analyses on binding sites of targets suggested that the existence 
of both multiple TFBSs in a cluster and multiple information- 
dense clusters in the same promoter enables both the cluster and 
the promoter to be resilient to mutations in individual TFBSs 
(Figure 5, Table 5).
The DT classifier improved after intersecting promoters with 
DHSs in prediction of TF targets with the CRISPR-generated 
knockdown data (Table 2). This intersection eliminated noisy bind-
ing sites that are inaccessible to TF proteins in promoters10,31,32; 
specifically, it widened discrepancies in feature vectors between 
positives and negatives. If the 10 kb promoter of a gene instance 
does not overlap DHSs, its feature vector will only consist of 
0; the percentages of negatives whose promoters do not over-
lap DHSs considerably exceeded those of positives (Additional 
file 822), which led to an excess of negatives with feature vec-
tors containing only 0 after intersection. This explains why these 
negatives are not DE targets of the TFs in the K562 and 
GM19238 cell lines, because their entire promoters are not 
open to TF molecules; other regulatory regions besides the 
proximal promoters (e.g. intronic enhancers46) still enable the 
TFs to effectively control the expression of the positives 
with inaccessible promoters. Compared to the other six TFs, 
the poorer performance of the classifier on YY1 (Table 2) is 
attributable to its smaller percentage of negatives with inaccessible 
promoters (Additional file 822) and the larger number of functional 
binding sites in the K562 cell line.
Mutation analyses revealed that some deleterious TFBS muta-
tions could be compensated for by other information-dense 
clusters in the same promoter (Figure 5, Table 5)2,47; thus, 
predicting the effects of mutations in individual binding sites 
might not be sufficient to interpret downstream effects without 
considering their context. Though other TFBS clusters may 
compensate and maintain gene expression, the promoter will 
likely exhibit lower levels of activity than the wild-type promoter, 
which is a recipe for achieving natural phenotypic diversity44. 
Few published studies in molecular diagnostics have specifically 
examined the effects of naturally occurring variants within 
clustered TFBSs. IDBC-based ML provides an alternative 
approach to predict deleterious mutations that impact (i.e. repress 
or abolish) transcription of target genes and result in abnormal 
phenotypes, and to minimize false positive calls of TFBS 
variants that alone would be expected to have little or no impact.
Apart from these TFs, the Bray-Curtis Similarity metric can be 
directly applied to identify the ground-truth genes with over-
all similar tissue-wide expression patterns to any other gene 
whose expression profile is known. Previous applications of this 
index include: a) measurement of the ecological transfer of spe-
cies abundance from dense to sparse plots48, b) comparative 
difference analyses of species quantities between reference 
and algorithm-derived metagenomic sample mixtures (https:// 
precision.fda.gov/challenges/3/view/results) and c) improvement of 
friend recommendations in geosocial networks by using it to 
compare users’ movement history49,50.
These results stimulate questions about the biological signifi-
cance of genes sharing a common expression pattern, including 
the similarity between other regulatory regions besides proximal 
promoters in terms of TFBSs and epigenetic markers. This ML 
framework can also be applied to predict target genes for other 
TFs and in other cell lines, depending on the availability of 
corresponding knockdown data.
There are a number of limitations of our approach. The 
Bray-Curtis function seems unable to accurately measure the 
similarity between the tissue-wide expression profiles of a gene 
(e.g. MIR23A) without any detectable mRNA in any tissues and 
genes that are expressed in at least one tissue (e.g. ubiquitously 
expressed NR3C1 and stomach-specific PGA3). Intuitively, PGA3 
is more similar to MIR23A than NR3C1; however, the Bray-Curtis 
similarity indicates that both PGA3 and NR3C1 are equally 
dissimilar to MIR23A. The finite number of TFs analyzed is 
another possible limitation in the prediction of genes with similar 
expression profiles. This was due to a lack of iPWMs for 
other TFs that were knocked down. Given that 2000-3000 
sequence-specific DNA-binding TFs are estimated to be encoded 
in the human genome51, the CRMs of many genes under 
concerted regulation by different TFs will likely reveal complex 
circuitry that is currently unknown. For example, the iPWMs for 
several TFs (CREB, MYB, NF1, GRF1) that bind to the NR3C1 
gene promoter to activate or repress its expression could not 
be successfully derived from ChIP-seq data3,30. Regarding the 
CRISPR-generated knockdown data, positives were inferred 
to be direct targets by intersecting their promoters with corre-
sponding ChIP-seq peaks. This may not be completely accurate, 
due to the presence of noise peaks that do not contain true 
TFBSs3,52,53. Small fold changes in the expression levels of DE 
targets could arise from inefficient knockdown due to subop-
timal guide RNAs or to limitations of perturbing only a single 
allele encoding the TF54. Finally, the framework presented 
considers only the 10 kb interval proximal to the TSS. This 
could not capture long range enhancer effects beyond this point; 
a potential way of remediating this would be to incorporate 
correlation-based approaches that have successfully incorporated 
multiple definitions of promoter length15.
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Conclusions
We have developed a ML framework with a combination of 
information theory-based TF binding profiles of the spatial 
distribution and information contents of TFBS clusters, ChIP-seq 
and chromatin accessibility data. This framework distinguishes 
tissue-wide expression profiles of similar vs dissimilar genes 
(originally defined by the Bray Curtis function) and identified TF 
targets. Functional binding sites in target genes that significantly 
alter expression levels upon direct binding are at least partially 
distinguished by TF-cofactor coregulation from non-functional 
sites in non-targets. Finally, in-silico mutation analyses sug-
gested that the presence of multiple information-dense clusters 
in a target gene promoter is capable of mitigating the effects of 
deleterious mutations that can significantly alter TF-regulated 
expression levels.
bioRxiv




The median RPKM, TSS coordinate, DNase I hypersensitivity 
and ChIP-seq data were respectively obtained from the GTEx 
Analysis V6p release (www.gtexportal.org), Ensembl Biomart 
(www.ensembl.org) and ENCODE (www.encodeproject.org). The 
CRISPR- and siRNA-generated knockdown data were obtained 
from the supplementary information files of Dixit et al.16 and 
Cusanovich et al.14. The source datasets generated and/or analysed 
by this framework, along with sample results and compiled soft-
ware are available from Zenodo. DOI: https://doi.org/10.5281/ 
zenodo.170742321.
Data are available under the terms of the Creative Commons 
Zero “No rights reserved” data waiver (CC0 1.0 Public domain 
dedication).
Extended data
Additional files are available from Zenodo. DOI: https://doi.
org/10.5281/zenodo.261195322.
Additional file 1. The mathematical definitions of the four other 
similarity metrics, the workflow of the IDBC algorithm, an 
example feature vector, the mathematical definitions of five sta-
tistical variables to measure classifier performance, the default 
parameter values of classifiers in MATLAB, and histograms 
visualizing the first two criteria for selecting positives from 
the CRISPR-generated knockdown data.
Additional file 2: The lists of positives and negatives in the ML 
classifiers to predict genes with similar tissue-wide expression 
profiles to NR3C1.
Additional file 3: The lists of positives and negatives in the DT 
classifier to predict TF targets based on the CRISPR-generated 
knockdown data.
Additional file 4: The lists of positives and negatives in 
the DT classifier to predict DE direct targets based on the 
siRNA-generated knockdown data.
Additional file 5: The performance of the DT classifier using 
only TFBS counts, accuracy of each round of 10-fold cross 
validation, and Gini importance values of the ML features.
Additional file 6: The list of the most similar 500 PC genes to 
each TF in terms of tissue-wide expression profiles, and the inter-
section of these 500 genes and target genes of the TF.
Additional file 7: Cofactor binding sites adjacent to YY1 and 
EGR1 sites in the promoters of their targets and non-targets.
Additional file 8: The percentages of positives and negatives 
whose promoters do not overlap DHSs for the CRISPR-perturbed 
TFs.
Data are available under the terms of the Creative Commons 
Zero “No rights reserved” data waiver (CC0 1.0 Public domain 
dedication).
Software availability
Source code implementing the ML framework, including 
generating the figures in this article, is available at: https://
bitbucket.org/cytognomix/information-dense-transcription- 
factor-binding-site-clusters/.
Archived source code at time of publication: https://doi.
org/10.5281/zenodo.189205156.
License: GNU General Public License 3.0.
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 Gene 1 and 3 will be more similar according to Bray-Curtis Similarity. The inference is as follows:




2/11. sim  (G1,G2) = 
The Bray-Curtis similarity value between Gene 1 and Gene 3 is:
(3a+b)/(2a+2b).sim  (G1,G3) = 
Thus,  > sim  (G1,G3) sim  (G1,G2).
However, this is not unreasonable. In other words, this is not a problem, thus it does not need to be
















between Gene   and Gene   is identical to that between Gene   and Gene  , and the distanceA C B C
between   and   is larger than that between   and  ; thus,  . Similarly, theA C B C sim (A,C) < sim (B,C)
distance between   and   is identical to that between   and  , and the angle between   and   isA D E F A D
larger than that between   and  ; thus,  .E F sim(A,D) < sim(E,F)
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